Skip to content
    ABOS stock page

    Acumen Pharmaceuticals, Inc.

    ABOS · earnings call history

    1 call analysed
    1. Jun 2026Q2 FY26Aug 12, 2026

      Acumen Q2 FY26 — Phase II ALTITUDE-AD Readout Expected Late 2026; EBD Program Advances

      Read the brief

    Browse all US companies on the earnings-call register.